Sep 1, 2026 07:36AM

Aug 10, 2026 04:18PM

Aug 3, 2026 09:03AM

Jun 12, 2026 07:01AM

May 7, 2026 05:54PM

Apr 28, 2026 09:20AM

Apr 28, 2026 07:00AM Rocket Pharmaceuticals sells priority review voucher for $180 million

Mar 27, 2026 04:20PM

Mar 27, 2026 03:02PM

Mar 27, 2026 12:06PM

Mar 27, 2026 12:00PM

Mar 2, 2026 04:22PM

Feb 26, 2026 05:16PM

Nov 18, 2025 05:06AM JPMorgan Downgrades Rocket Pharmaceuticals (RCKT) to Underweight

Nov 6, 2025 06:54PM

Oct 14, 2025 07:00AM

Oct 6, 2025 05:27AM

Oct 3, 2025 04:36PM

Oct 3, 2025 10:35AM

Oct 3, 2025 07:06AM

Sep 22, 2025 07:21AM Cantor Fitzgerald Reiterates Overweight Rating on Rocket Pharmaceuticals (RCKT)

Aug 28, 2025 09:52AM

Aug 25, 2025 04:12PM

Aug 21, 2025 06:22AM

Aug 20, 2025 02:11PM

Aug 20, 2025 01:58PM

Aug 8, 2025 05:35AM

Aug 7, 2025 09:25AM RCKT 4-DAY DEADLINE ALERT: FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action - Hagens Berman

Jul 29, 2025 03:05PM

Jul 25, 2025 06:34AM

Jul 25, 2025 06:14AM

Jul 24, 2025 07:00AM

Jul 23, 2025 04:31PM

Jul 22, 2025 05:25PM

Jul 22, 2025 05:05PM ROSEN, A TOP RANKED LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RCKT

Jul 22, 2025 03:51PM

Jul 22, 2025 12:38PM

Jul 21, 2025 05:00PM

Jul 20, 2025 05:00PM

Jul 20, 2025 04:00PM

Jul 19, 2025 03:24PM

Jul 19, 2025 08:05AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 18, 2025 03:19PM

Jul 18, 2025 01:07PM

Jul 18, 2025 12:27PM

Jul 18, 2025 06:15AM

Jul 17, 2025 03:13PM

Jul 17, 2025 07:00AM

Jul 16, 2025 04:16PM CLASS ACTION NOTICE: Berger Montague Advises Rocket Pharmaceuticals (RCKT) Investors to Inquire About a Securities Fraud Class Action

Jul 15, 2025 12:17PM

443,852 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All